from chatGPT:Here’s a list of some biotech companies that have issued convertible bonds, including the year and the total amount where available:
1. Moderna, Inc.
- Year Issued: 2021
- Amount: $1.34 billion
- Details: Moderna issued convertible senior notes due in 2026 to support its ongoing research and development efforts, including vaccine development.
2. Gilead Sciences, Inc.
- Year Issued: 2020
- Amount: $3.5 billion
- Details: Gilead issued convertible senior notes to strengthen its balance sheet and fund its strategic initiatives, including potential acquisitions and R&D.
3. Illumina, Inc.
- Year Issued: 2021
- Amount: $2 billion
- Details: Illumina issued convertible senior notes to finance its acquisition of Grail and support its growth strategy.
4. Biogen Inc.
- Year Issued: 2020
- Amount: $1.5 billion
- Details: Biogen issued convertible senior notes to fund its research and commercial activities.
5. Vertex Pharmaceuticals Incorporated
- Year Issued: 2019
- Amount: $1.4 billion
- Details: Vertex issued convertible senior notes to support its ongoing research and development programs.
6. Sarepta Therapeutics, Inc.
- Year Issued: 2017
- Amount: $750 million
- Details: Sarepta issued convertible senior notes to finance its gene therapy initiatives and other research programs.
7. Neurocrine Biosciences, Inc.
- Year Issued: 2022
- Amount: $500 million
- Details: Neurocrine issued convertible senior notes to support its R&D and operational needs.
8. NantKwest, Inc.
- Year Issued: 2021
- Amount: $200 million
- Details: NantKwest issued convertible senior notes to fund its clinical trials and product development.
- Forums
- ASX - By Stock
- TLX
- Ann: Telix Successfully Prices A$650M Convertible Bonds
Ann: Telix Successfully Prices A$650M Convertible Bonds, page-69
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLX (ASX) to my watchlist
|
|||||
Last
$18.61 |
Change
0.130(0.70%) |
Mkt cap ! $6.227B |
Open | High | Low | Value | Volume |
$18.69 | $18.80 | $18.37 | $19.72M | 1.061M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 161 | $18.60 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.62 | 450 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 26 | 18.450 |
1 | 108 | 18.430 |
1 | 163 | 18.350 |
1 | 5000 | 18.310 |
3 | 6163 | 18.300 |
Price($) | Vol. | No. |
---|---|---|
18.620 | 450 | 1 |
18.700 | 400 | 1 |
18.900 | 1500 | 1 |
19.010 | 3200 | 2 |
19.050 | 512 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
TLX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online